# HCPCS J2503: Injection, pegaptanib sodium, 0.3mg

Medicare does not publish a national rate for HCPCS J2503; it is priced locally or only by commercial payers.

Web page: https://www.med-reveal.com/rates/J2503-hcpcs-fee-schedule
Section: Drugs and Biologicals


## Related codes

- J0517: Injection, benralizumab, 1mg — https://www.med-reveal.com/rates/J0517-hcpcs-fee-schedule
- J0638: Injection, canakinumab, 1mg — https://www.med-reveal.com/rates/J0638-hcpcs-fee-schedule
- J0717: Injection, certolizumab pegol, 1mg — https://www.med-reveal.com/rates/J0717-hcpcs-fee-schedule
- J1602: Injection, golimumab, 1mg — https://www.med-reveal.com/rates/J1602-hcpcs-fee-schedule
- J2182: Injection, mepolizumab, 1mg — https://www.med-reveal.com/rates/J2182-hcpcs-fee-schedule
- J3262: Injection, tocilizumab, 1mg — https://www.med-reveal.com/rates/J3262-hcpcs-fee-schedule
- J3380: Injection, vedolizumab, 1mg — https://www.med-reveal.com/rates/J3380-hcpcs-fee-schedule
- J9227: Injection, isatuximab-irfc, 10mg — https://www.med-reveal.com/rates/J9227-hcpcs-fee-schedule

Commercial negotiated rates for J2503 by payer and state: https://www.med-reveal.com/solutions/rate-benchmarking

## Sources

- CMS Medicare fee schedules: https://www.cms.gov/medicare/payment/fee-schedules